A new longitudinal study published in the Journal of the American Academy of Dermatology evaluated more than a decade of data from adults living with HIV, revealing a steady decline in dermatologic disease...
Recent studies show distinct metabolic disruptions in children with multisystem inflammatory syndrome in children, plaque progression in adults post–COVID-19, and surprising pneumococcal risk patterns.
...
A randomized, double-blind, placebo-controlled crossover study found that a single 300 mg dose of palmitoylethanolamide significantly reduced acute menstrual pain compared with placebo at multiple early...
In a novel organ-on-chip model, aspirin demonstrated protective effects on placental cells under inflammatory conditions, while indomethacin was associated with increased cytotoxicity across all cell types....
A recent feasibility study evaluated the acceptability and impact of smartphone notifications on medication adherence in patients with gout prescribed allopurinol.
In a phase 3 trial, inebilizumab, a monoclonal antibody targeting CD19+ B cells, reduced flare rates and improved treatment-free and glucocorticoid-free remission in patients with immunoglobulin G4-related...
A multicenter, randomized controlled trial revealed that continuing immunosuppressants, with or without low-dose glucocorticoids, reduces relapse rates for patients with stable IgG4-related disease compared...
In a study that assessed pericoronary adipose tissue (PCAT) density, researchers noted an association between higher PCAT density and greater coronary plaque burden and cardiovascular disease in people with...
In a cohort study, researchers observed a significant decrease in incident reinfection among patients with Hepatitis C who received increased follow-up after achieving sustained virologic response.
Researchers who are a part of the American Gastroenterological Association (AGA) developed a list of guidelines for the use of fecal microbiota-based therapies in patients with Clostridioides difficile...
